Literature DB >> 10872425

Molecular genetic alterations in ductal pancreatic adenocarcinomas.

S E Kern1.   

Abstract

Pancreatic ductal adenocarcinomas are known to harbor a distinct variety of genetic alterations in oncogenes, tumor-suppressor genes, and occasionally genes that carry out DNA mismatch repair. Although this malignancy occurs at an elevated frequency in patients with familial recurrent acute pancreatitis, the genetic alterations of these particular tumors have not been reported. The changes are likely to be similar to those of sporadic pancreatic cancer; if so, this would provide useful clues for studying the progression of early and advanced neoplasia in such pancreatitis patients to aid their clinical monitoring and provision of therapeutic recommendations.

Entities:  

Mesh:

Year:  2000        PMID: 10872425     DOI: 10.1016/s0025-7125(05)70251-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  17 in total

1.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

2.  Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.

Authors:  A Jesse Gore; Samantha L Deitz; Lakshmi Reddy Palam; Kelly E Craven; Murray Korc
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

3.  Screening for pancreatic cancer: current evidence and future directions.

Authors:  Julia B Greer; Randall E Brand
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

Review 4.  Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.

Authors:  Bumsoo Han; Chunjing Qu; Kinam Park; Stephen F Konieczny; Murray Korc
Journal:  Cancer Lett       Date:  2015-12-10       Impact factor: 8.679

5.  5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.

Authors:  René Hennig; Xian-Zhong Ding; Wei-Gang Tong; Matthias B Schneider; Jens Standop; Helmut Friess; Markus W Büchler; Parviz M Pour; Thomas E Adrian
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Restoration of silenced Peutz-Jeghers syndrome gene, LKB1, induces apoptosis in pancreatic carcinoma cells.

Authors:  Suparna Qanungo; Subrata Haldar; Aruna Basu
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

7.  Development of orthotopic pancreatic tumor mouse models.

Authors:  Wanglong Qiu; Gloria H Su
Journal:  Methods Mol Biol       Date:  2013

Review 8.  Primers on molecular pathways. The glycogen synthase kinase-3beta.

Authors:  Daniel D Billadeau
Journal:  Pancreatology       Date:  2007-10-01       Impact factor: 3.996

9.  Pancreatic adenocarcinoma: new strategies for success.

Authors:  Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2009-03

10.  Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth.

Authors:  S J Deharvengt; J R Gunn; S B Pickett; M Korc
Journal:  Cancer Gene Ther       Date:  2009-10-23       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.